M&A Corporate Practice
CBC advises clients on corporate matters, including M&A transactions worldwide. Our M&A team is experienced in buy and sell side transactions across a wide range of industries and geographies, including deals in highly regulated industries subject to government scrutiny. We strive to understand our clients’ business and industry, and we approach each engagement in an customized manner that meets the client’s goals and challenges.
CBC’s M&A team is committed to using technology to reduce the costs of M&A transactions. For example, we reduce the costs of the due diligence process by utilizing the Deal Driver platform of our CBC Alliance Partner, Flatiron Law Group LLP. In addition, in most cases, we are able to complete M&A deals on an affordable flat fee basis.
Select List of M&A Transaction
The following is a select list of M&A transactions handled by CBC Founding Partner, Zhang Ning, and by our CBC Alliance Partners, Conrad Everhard Leonard T. Nuara:
CBC’s M&A team is committed to using technology to reduce the costs of M&A transactions. For example, we reduce the costs of the due diligence process by utilizing the Deal Driver platform of our CBC Alliance Partner, Flatiron Law Group LLP. In addition, in most cases, we are able to complete M&A deals on an affordable flat fee basis.
Select List of M&A Transaction
The following is a select list of M&A transactions handled by CBC Founding Partner, Zhang Ning, and by our CBC Alliance Partners, Conrad Everhard Leonard T. Nuara:
- Represented Shanghai Automobile Air Conditioning Factory (SAACF) in the acquisition of Dephi Automotive’s equity interest in a joint venture with SAACFRepresented a major U.S. high tech company in strategic acquisitions of various companies or assets, involving deep learning, cloud technology, CDMA business, etc.
- Represented Google Capital in a proposed acquisition of an online education site in China
- Represented Hepalink, a Chinese company listed on Shenzhen Stock Exchange, in its acquisition of its competitor in the U.S. and its investment in a medical fund in the U.S.
- Represented ICBC in its acquisition of a Taiwan commercial bank
- Represented owners of a Chinese hospital restructure its business in a sale to a British strategic investor
- Represented certain medical fund in China to invest in various U.S. companies in Pre-IPO rounds
- Represented a well-known U.S. pharmaceutical company in its investment in Chinese pharmaceutical companies through its fund in Asia
- Represented a private equity firm in its proposed acquisition of assets in connection with the bankruptcy of a media company.
- Represented a Taiwan-based global top ten solar cell manufacturer in its acquisition of a solar photovoltaic module assembly operation located in Newark, Delaware, the first acquisition by an Asian-based solar manufacturer of a U.S. solar panel facility.
- Represented a fintech company in its sale to a public software company.
- Represented a biopharmaceuticals company developing therapeutics to treat chronic kidney disease in its sale to a public biopharmaceuticals company.
- Represented a Pennsylvania-based renewable energy company in connection with the sale of its advanced intellectual property assets to one of the world’s leading solar module manufacturers based in mainland China for consideration consisting of cash and a performance based earn-out; subsequently represented the client in arbitration to enforce the payment of the earn-out, resulting in a substantial settlement for the client.
- Represented the clean energy division of a European-based global energy conglomerate in connection with its acquisition of a Boston-based biofuels portfolio company via reverse triangular merger; subsequently created a consulting and stock option package for the original founder which contained a complex performance-based vesting protocol tied to the achievement of R&D milestones.
- Represented the clean energy division of a European-based global energy conglomerate in connection with the sale of intellectual property assets related to its biofuels portfolio to a Boston based biotech SPAC.
- Represented the leading French internet auction site in connection with the sale of the company to a U.S.-based public company for approximately $100 million in stock.
- Represented a leading provider of automated helpdesk software in connection with the sale of the company to the largest public anti-virus software company for consideration consisting of approximately $120 million in cash.
- Represented a paper packaging manufacturer formerly listed on the New York Stock Exchange in connection with its acquisition of manufacturing facilities and other assets in the United States and Canada via several transactions aggregating $200 million.
- Represented a New York-based regional supplier of telecommunications components in connection with a sale of the company to a public company for approximately $20 million in cash and securities.
- Represented a New Jersey-based spin-off of a company active in the voice application sector in connection with the sale of the company to a public company.
- Represented a developer of virtual storage software and consulting solutions in connection with the acquisition of a New England-based network integrator for cash and private securities.
- Represented a New York City-based developer of middle market software for architects and engineers in connection with the sale of the company to a public company for cash.
- Represented a developer of sales tax management software in connection with the sale of the company to a large publication house for cash.